Group B streptococcus in prosthetic hip and knee joint-associated infections

Journal of Hospital Infection

Volumn 79, Issue 1, 2011, Pages 64-69

  Sendi, P ^a   Christensson, B ^b   Uckay I ^c   Trampuz, A ^d   Achermann, Y ^e   Boggian, K ^f   Svensson, D ^b   Widerstrom M ^g   Zimmerli, W ^a  

^a University Medical Clinic Liestal   (Switzerland)

^b LUND UNIVERSITY   (Sweden)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e Department of Urology Hospital of the Canton of Zug   (Switzerland)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^g ÖSTERSUND HOSPITAL   (Sweden)

Author keywords

Group B streptococcus; Prosthesis related infections; Streptococcus

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; FLUCLOXACILLIN; LEVOFLOXACIN; LINEZOLID; PENICILLIN DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

ACUTE DISEASE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; BACTEREMIA; CHILL; COMORBIDITY; DEBRIDEMENT; DEVICE REMOVAL; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FEVER; FOLLOW UP; FUNCTIONAL STATUS; GROUP B STREPTOCOCCAL INFECTION; HIP PROSTHESIS; HUMAN; KNEE PROSTHESIS; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SOFT TISSUE INJURY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; TREATMENT DURATION; UREAPLASMA UREALYTICUM;

AGED; ANTI-BACTERIAL AGENTS; DEBRIDEMENT; FEMALE; HIP JOINT; HUMANS; KNEE JOINT; MALE; OSTEOARTHRITIS; PROSTHESIS RETENTION; PROSTHESIS-RELATED INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TREATMENT OUTCOME;

EID: 80051474746     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.04.022     Document Type: Article

References (31)

1. Skoff T.H., Farley M.M., Petit S., et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009, 49:85-92.
2. Sendi P., Johansson L., Norrby-Teglund A. Invasive group B Streptococcal disease in non-pregnant adults: a review with emphasis on skin and soft-tissue infections. Infection 2008, 36:100-111.
3. Duggan J.M., Georgiadis G., VanGorp C., Kleshinski J. Group B streptococcal prosthetic joint infections. J South Orthop Assoc 2001, 10:209-214. discussion 14.
4. Meehan A.M., Osmon D.R., Duffy M.C., Hanssen A.D., Keating M.R. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 2003, 36:845-849.
5. Small C.B., Slater L.N., Lowy F.D., Small R.D., Salvati E.A., Casey J.I. Group B streptococcal arthritis in adults. Am J Med 1984, 76:367-375.
6. Zeller V., Lavigne M., Leclerc P., et al. Group B streptococcal prosthetic joint infections: a retrospective study of 30 cases. Presse Med 2009, 38:1577-1584.
7. Hyman J.L., Salvati E.A., Laurencin C.T., Rogers D.E., Maynard M., Brause D.B. The arthroscopic drainage, irrigation, and debridement of late, acute total hip arthroplasty infections: average 6-year follow-up. J Arthroplasty 1999, 14:903-910.
8. Everts R.J., Chambers S.T., Murdoch D.R., Rothwell A.G., McKie J. Successful antimicrobial therapy and implant retention for streptococcal infection of prosthetic joints. Aust NZ J Surg 2004, 74:210-214.
9. Zimmerli W., Trampuz A., Ochsner P.E. Prosthetic-joint infections. N Engl J Med 2004, 351:1645-1654.
10. Trampuz A., Piper K.E., Jacobson M.J., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007, 357:654-663.
11. Giulieri S.G., Graber P., Ochsner P.E., Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004, 32:222-228.
12. Bliss D.G., McBride G.G. Infected total knee arthroplasties. Clin Orthop Relat Res 1985, 199:207-214.
13. Peersman G., Laskin R., Davis J., Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001, 392:15-23.
14. Segreti J., Nelson J.A., Trenholme G.M. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 1998, 27:711-713.
15. Stuesse D.C., Robinson J.H., Durzinsky D.S. A late sternal wound infection caused by hematogenous spread of bacteria. Chest 1995, 108:1742-1743.
16. Levine M.J., Mariani B.A., Tuan R.S., Booth R.E. Molecular genetic diagnosis of infected total joint arthroplasty. J Arthroplasty 1995, 10:93-94.
17. Widmer A.F., Gaechter A., Ochsner P.E., Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992, 14:1251-1253.
18. Triesenberg S.N., Clark N.M., Kauffman C.A. Group B streptococcal prosthetic joint infection following sigmoidoscopy. Clin Infect Dis 1992, 15:374-375.
19. Cunningham R., Walker C., Ridgway E. Prosthetic hip-joint infection associated with a penicillin-tolerant group B streptococcus. J Infect 1992, 25:77-81.
20. Passick J., Hirsh D.M. Recurrent infection of a total hip arthroplasty associated with radiation-induced ulcerative colitis. A case report. J Arthroplasty 1989, 4:87-90.
21. Ahlberg A., Carlsson A.S., Lindberg L. Hematogenous infection in total joint replacement. Clin Orthop Relat Res 1978, 137:69-75.
22. Downes E.M. Late infection after total hip replacement. J Bone Joint Surg Br 1977, 59:42-44.
23. Zeller V., Lavigne M., Biau D., et al. Outcome of group B streptococcal prosthetic hip infections compared to that of other bacterial infections. Joint Bone Spine 2009, 76:491-496.
24. Marculescu C.E., Berbari E.F., Hanssen A.D., et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006, 42:471-478.
25. Karunakar M.A., Shah S.N., Jerabek S. Body mass index as a predictor of complications after operative treatment of acetabular fractures. J Bone Joint Surg Am 2005, 87:1498-1502.
26. Malone D.L., Genuit T., Tracy J.K., Gannon C., Napolitano L.M. Surgical site infections: reanalysis of risk factors. J Surg Res 2002, 103:89-95.
27. Baker C.N., Thornsberry C., Facklam R.R. Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother 1981, 19:716-725.
28. Melin P., Lorquet S., Hayette M.P., De Mol P. Killing kinetics of group B streptococci for penicillin in combination with gentamicin. Int Congr Ser 2006, 1289:103-106.
29. Sendi P., Ericsson M., Olaison L. Group B streptococcus in infective endocarditis. Interscience conference of antimicrobial agents and chemotherapy 2008 2008, American Society for Microbiology, Washington DC, p. 558 (Abstract k-3753).
30. Betriu C., Gomez M., Sanchez A., Cruceyra A., Romero J., Picazo J.J. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother 1994, 38:2183-2186.
31. Zimmerli W., Sendi P. Antibiotics for prevention of periprosthetic joint infection following dentistry: time to focus on data. Clin Infect Dis 2010, 50:17-19.